Increased demand for a range of health care and medical devices has seen Omega Group invest more than £200,000 ($249,000) in new technology at its plant in northeast England.
The company injection molds components used in surgery, medical testing and trials. The new Fanuc machinery is for Omega's plant in Hartlepool.
Omega Plastics managing director Gary Powner, said: “The diversity and growth in the medical devices industry make this a fundamentally important market for our business. This is just the latest in a line of investments we have made in our people and the technologies they work with to ensure we consistently deliver the highest quality products and services to our customers.
“The sector is understandably heavily regulated, especially in the supply of products and materials that are intended to come into direct contact with humans. Fanuc's purpose-built machines enable us to create exactly the right conditions for manufacturing these highly sensitive products.”
Omega Group formed a year ago from the merger of Blyth, England-based Omega Plastics Ltd. with Washington, England-based Signal Plastic Components Ltd.
Omega Group supplies tooling, molding and rapid production to automotive, electronics, fast-moving consumer goods, medical, personal care and bio-tech customers.